Provision of end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting

University Hospitals Plymouth is initiating a procurement process for the provision of an end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting. The industry category is pathology services, and the procurement is at the planning stage. Situated in Plymouth, United Kingdom, the contracting authority will follow the Most Suitable Provider route under the NHS Provider Selection Regime (PSR).

Key dates include the tender period ending on 16 January 2026, and the start of the contract scheduled for 1 February 2026. This planned procurement is valued at £275,000 with a contract period lasting until 31 March 2027, and renewal options to be confirmed later. This opportunity offers significant growth for businesses specialising in digital diagnostic services, particularly those focused on cancer diagnostics, due to the integrated AI support and NHS collaboration.

Companies that can deliver streamlined and efficient laboratory processes, and offer a digital ecosystem for data capture and reporting, will find this contract particularly beneficial. With selective procurement methods aimed at dynamic market references, businesses capable of innovative solutions in pathology and clinical data integration are well-positioned to compete in this process. Key stakeholders include Rob Archer, Operations Manager, and Mark Austin, Clinical Support Category Manager, providing strategic direction for this valuable project.